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Introduction α-synuclein has been widely studied for its crucial role in Parkinson's disease. This intrinsically disordered protein forms a 25 shallowly inserted amphipathic helix after binding to a membrane bilayer containing negatively charged lipids, and this binding can lead to membrane remodelling 1-4 . Significant efforts using a wide range of different techniques have been dedicated to elucidating the membrane remodelling ability of α-synuclein. In EM studies, 30 vesicles were observed to deform into cylindrical tubes or micelles when co-incubated with α-synuclein [5] [6] [7] [8] . AFM, NMR as well as X-ray scattering studies, have indicated α-synuclein to stretch the bilayer upon binding and therefore to induce membrane-thinning [9] [10] [11] . However, the underlying mechanisms 35 and connections between these biophysical phenomena are still missing.
In neurons, α-synuclein has a concentration of tens of micromolars and is speculated to modulation the fusion of synaptic vesicles into the plasma membrane [12] [13] [14] [15] [16] . Recent 40 experiments also suggest that α-synuclein plays a positive role in the early steps of endocytosis 17 . Therefore, elucidating the mechanism of α-synuclein membrane interaction is a critical step towards understanding the physiological and pathological functions of α-synuclein. 45 Here, the membrane remodelling ability of α-synuclein is studied on individual giant unilamellar vesicles (GUVs). A substantial membrane area expansion is observed followed by fragmentation or tubulation of the membrane. The extent of membrane expansion correlates linearly with the α-synuclein density on the 50 GUV, resulting in an area expansion per synuclein molecule larger than the area of the membrane binding site of the protein.
The area expansion constant is independent of membrane tension and vesicle size, indicating that the expansion phenomenon is not a result of the protein's effect on the membrane undulation (out-55 of-plane fluctuation) spectrum. However, a strong dependence of the area expansion constant on lipid composition is observed, with a significantly larger expansion effect (per protein molecule) on a cell mimicking lipid composition than on membranes composed only of DOPS. We used a fluorescence quenching 60 assay to confirm that lipid flip-flop across the bilayer is not significantly enhanced in the presence of α-synuclein, implying that the area expansion effect is related to membrane thinning as opposed to the redistribution of lipids across the bilayer due to asymmetric α-synuclein insertion. 65 Significant membrane thinning effects have been found for many membrane interacting peptides or proteins [18] [19] [20] . To our knowledge, however, the contribution from individual molecules has not yet been quantified either due to inherent limits of the technique used or due to a nonlinear thinning behaviour found for several peptides 20, 21 . Finally, in addition to membrane expansion, our experimental approach allows us to monitor tubulation transitions following the area expansion process. Membrane expansion and tubulation are likely two interrelated α-synuclein membrane interaction modes operating in different α-synuclein density 5 regimes. We believe our results enhance the understanding of α-synuclein membrane interactions and provide useful insights in understanding the biological roles of this protein.
Experimental section

Materials
10
Lipids 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS), 1,2-dioleoyl-snglycero-3-phosphoethanolamine (DOPE), and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) were obtained from Avanti Polar Lipids (Alabaster,AL). Alexa Fluor® 488 (AF-488) 15 C5-maleimide, BODIPY® FL DHPE (N-(4,4-Difluoro-5,7-Dimethyl-4-Bora-3a,4a-Diaza-s-Indacene-3-Propionyl)-1,2-Dihexadecanoyl-sn-Glycero-3-Phosphoethanolamine, Triethylammonium Salt), NBD-PE (N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)-1,2-Dihexadecanoyl-sn-Glycero- [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Phosphoethanolamine, Triethylammonium Salt) and Texas Red-1,2-dihexadecanoyl-sn-glycero-3 phosphoethanolamine (Triethylammonium salt) were from Life Technologies (Grand Island, NY). Na2S2O4 (SDT), casein, Tris, HEPES, and EDTA were obtained from Fisher Scientific (Rochester, NY). All 25 commercial reagents were used without further purification.
Protein purification
N-terminally acetylated α-synuclein bearing an S9C mutation (mol. wt. = 14.5 kDa) was expressed, purified and then labelled with Alexa-488 maleimide at S9C as previously described 22, 23 .
30
ENTH_GFP was expressed and purified following ref 24 . Both proteins were stored at -80 ℃ after purification. Thawed proteins were kept on ice before fluorescence imaging. All measurements were taken within five days after thawing the protein.
Imaging chamber preparation and GUV transfer procedures
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GUVs were prepared by electroformation in 300mM sucrose solution with 0.3%Texas Red-DHPE in desired lipid compositions as previously described 25 . Two imaging compartments, a GUV chamber and a protein chamber, were formed between two coverslips (20mm×40mm, pre-treated with 40 2μL of 2.5mg/ml casein, 20mM Tris, and 2mM EDTA) overhanging a glass microscope slide (2mm thick) 26 . The GUV chamber had a total volume of 375μL and was made by diluting 5~15μL of the GUV stock solutions into a buffer containing glucose, sucrose, NaCl and HEPES. The osmolarity of the buffer 45 was selected to be 20% higher than the GUV stock solution (measured with a micro-osmometer Advanced Instruments Inc. (Norwood, MA)) to ensure that the vesicles had enough excess area for micropipette aspiration. The protein chamber had a total volume of 187.5μL. The protein stock solution was diluted to 50 designated concentrations, using the same buffer as used for diluting GUVs. For both chambers, we chose pH = 7 and NaCl was kept at 50mM, with 7mM HEPES. Sucrose and glucose (1:1) concentrations were adjusted to yield total osmolarities of the desired values. Micropipettes and transfer capillaries were 55 prepared and casein-treated as described 25, 27 . GUVs were prestretched under a membrane tension >0.5mN/m before step 2 of the transfer process (Fig.1) . Zero aspiration pressure was checked before and after the protein-GUV association process to ensure absence of pressure drifts 28 . All the transfer and imaging 60 processes were carried out at room temperature (24 ℃).
Microscopy and data analysis
The protein-membrane association process and the membrane geometry changes were monitored with a confocal fluorescence microscope 25 , using a 60x 1. Gaussian ring to the GUV contour (excluding the aspirated region) using MATLAB. Rv could also be obtained from the fitting and was double-checked through direct measurement via Image J. The measured fluorescence intensity was then converted into a protein monomer density ρ(t) following Ref. 29 . GUVs containing 75 x% BODIPY and (100-x)% DOPC were prepared (x: 0.1~2) and at least 20 independent GUVs were imaged under the same settings as during the recording of GUV-protein association. A linear fit (r 2 =0.99) was carried out to obtain the relation between measured GUV fluorescence intensity and BODIPY density on 80 the membrane. The quantum yield difference between BODIPY and AF-488 was determined to be BODIPY/'AF-488'=0.5, by imaging bulk solution intensity of SUVs (containing BODIPY) and AF-488 labelled proteins under the same solution conditions as in our experiments (50mM NaCl, pH 7) 30 . The average lipid 85 headgroup area was assumed as 0.7 nm 2 . The membrane instability point tc was defined as the time point when Area(t) begins to decrease, and the corresponding protein density ρ(tc) was defined as the instability transition-density.
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Fig. 1 Experimental Method:
Membrane shape transitions studied by single GUV transfer method. a) A schematic representation of a pipette-aspirated GUV. Rv and Rp are the radii of the GUV and aspiration pipette respectively. Lp is the aspiration length, ΔP is the aspiration pressure. b) The process of transferring a 95 single GUV from a GUV dispersion (red) to a protein solution (green) (See reference 31 for more details). During the binding of α-synuclein onto the transferred GUV, membrane area and protein density on the membrane (determined from the protein's fluorescence intensity) were monitored simultaneously.
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Zeta potential measurements
We measured the electrophoretic mobility of LUVs under the same experimental conditions as in other experiments with a Delsa Nano C Particle Analyzer. The HelmholtzSchmoluchowski relation was used to convert the measured 105 mobility to zeta potential. LUVs (DOPS/DOPE/DOPC=45/30/25, or pure DOPS) were prepared in 300mM sucrose and extruded 23 times with 100nm pore size filters. Each measurement was repeated three times.
Fluorescence spectroscopy
110
LUVs (99%DOPS and 1%NBD-PE) were prepared in 300mM sucrose and extruded 23 times with 100nm pore size filters. Fluorescence signals of NBD were collected with a Cary Eclipse fluorometer with single wavelength excitation at 463nm for LUV solutions under various experimental conditions. Peaks of the 5 emission spectra (at 536nm) were used to calculate the amount of fluorescence quenching in the presence of Na2S2O4 (SDT).
Results and discussion
Binding of α-synuclein linearly increases the membrane area
To study the α-synuclein induced membrane-remodelling process, 10 we employed a single GUV analysis method recently developed by us ( Fig. 1 ) 26, 27 . Briefly, individual pipette-aspirated GUVs were transferred into solutions containing a fixed concentration of α-synuclein monomers. GUV area and α-synuclein density on the membrane were recorded simultaneously once the vesicle is 15 exposed to the α-synuclein solution. As shown in Fig. 2a , the binding of α-synuclein is accompanied by an increase of the GUV's pipette aspiration length as well as a dilution of lipid dye in the membrane ( For pure DOPS GUVs in a 250nM α-synuclein solution, the area expansion constant is found to be 22.2±5.4nm 2 (Mean±SD from 24 GUVs), which is slightly larger than the size of the membranebinding site of α-synuclein determined from molecular dynamic simulation studies (about 15 nm 2 ) 11 . The linearity between α-30 synuclein density and membrane area expansion clearly indicates that when expanding the bilayer, contributions from individual α-synuclein molecules are linearly additive. In other words, protein cooperativity on the membrane does not contribute significantly to the membrane expansion under situations we consider here.
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Molecular dynamics studies comparing the membrane remodelling abilities of single versus multiple α-synucleins demonstrated similar additive behaviour 11 . However, this is not a universal feature of protein/peptide induced membrane expansions. For example, non-linear area-density relations were 40 observed when the same experiment was repeated for ENTH domains (Fig. S2) , and no expansion effect was observed for the endophilin N-BAR domain 26 . Both of these proteins are endocytic accessory proteins with well documented membrane insertion abilities 32 . As expected, a significantly lower amount of α-synuclein can associate onto the biologically more relevant composition. This agrees with the facts that α-synuclein membrane interaction is 80 dominated by electrostatics 1 , and that the zeta-potentials 34 that we determined have values of -50.7±2.3mV (Mean±SD) for the composition of DOPS/DOPE/DOPC = 45/30/25, and -65.7±2.6mV (Mean±SD) for pure DOPS membrane. However, as shown in Fig. 3a , similar total area increase can be achieved on 85 both types of membranes, resulting in an area expansion constant significantly larger on membranes with PE and PC than on the pure PS membrane (Fig. 3b) . Therefore, we expect the membrane area expansion induced by α-synuclein binding to be an important effect in cellular events, with the amount of expansion by 90 individual α-synuclein molecules significantly larger than its cross-section area on the membrane 11 . The membrane with more biological lipid composition may have a smaller transverse elastic modulus compared to the pure DOPS membrane. This could contribute to the much larger area expansion constant observed 95 on the DOPS/DOPE/DOPC = 45/30/25 GUVs as will be discussed later. α-synuclein may also reduce the lateral expansion of PS lipids due to the stronger interaction between the protein and the charged PS headgroup. Therefore, the smaller amount of PS on the cell mimicking GUV could be another source for the 100 larger area expansion effect. As for distinguishing the contributions of PE and PC to the membrane area expansion, unfortunately, α-synuclein binds very weakly on GUVs with DOPS/ DOPC=45/55 (protein density change < 200μm -2 ), making it impossible to accurately measure the area expansion 105 constant on this lipid composition with only PC and PS (Fig. S3 ).
Membrane expansion induced by α-synuclein is a reversible process
We then asked if the membrane expansion induced by α-synuclein is reversible, that is, whether membrane area will 110 decrease when α-synuclein molecules unbind from the membrane. To measure this, we transferred α-synuclein bound GUVs into a large volume of buffer solution containing small vesicles devoid of any α-synuclein. As expected, the GUV area decreases during α-synuclein dissociation, with a linear relation between the protein density and membrane area (Fig. 4) . The resulting area expansion constant qualitatively agrees with the value determined from α-synuclein membrane association studies (Fig. 3) . A variety of protein membrane interaction processes can lead to an increase in GUV membrane area. These could include: the formation membrane pores; direct stretching or thinning of the 20 lipid bilayer; smoothening of membrane undulations due to protein binding; protein membrane insertion followed by a rapid lipid flip-flop. To elucidate the underlying mechanism of α-synuclein induced membrane expansion, we next aim to discuss all of the scenarios considered above. 25 The formation of pores (larger than the size of α-synuclein) on the GUV can be easily excluded simply based on the fact that fluorescent α-synuclein cannot diffuse across the bilayer (Fig. S4) and that the GUV remains intact during the area expansion process (Fig. 1, Fig. 7b and Fig. S2b) . In the following, we will 30 focus on discussions regarding the interference of α-synuclein with: membrane undulation, transmembrane dynamics of lipids, membrane stretching, and membrane thinning. In order to achieve an accurate estimate of the area expansion constant, a large range of α-synuclein density change during protein-membrane 35 association is required (Fig. S5) . Therefore, in the following quantitative analyses, experiments were performed on GUVs comprised only of DOPS where typically an α-synuclein density change larger than 2000μm -2 can be observed during the proteinmembrane association process. 40 
The membrane expansion effect does not represent α-synuclein's effect on membrane undulations
Due to thermal fluctuations, a certain area fraction of freely suspended membranes is always stored as surface undulations which are typically beyond the spatiotemporal resolution of our 45 technique 26 . The amount of membrane undulation is inversely related to the membrane bending rigidity and tension. Consequently, an increase in the observed membrane area will happen when the binding of protein stiffens the membrane or locally increases membrane tension 35 . Therefore, the observed 50 area expansion effect may represent interference between α-synuclein and the membrane fluctuation spectrum.
In this scenario, one should expect the area expansion constant to be directly dependent on the initial global membrane tension adjusted by the aspiration pipette. That is, a smaller area 55 expansion constant is expected on GUVs of higher membrane tension (which show less undulation).
However, from our experimental data, no clear dependence can be identified between the area expansion constant and membrane tension (Fig. 5a) . In fact, a linear fit of the area expansion 60 constant to membrane tension yields a zero slope within statistical error. Therefore we conclude that the area expansion is not a result of smoothing out membrane undulation by α-synuclein membrane binding. We mention in passing that no dependence of the area expansion constant on the GUV radius 65 can be observed either (Fig 5b) . 
The membrane expansion effect does not represent α-synuclein's effect on trans-membrane lipid flip-flop dynamics
Membrane associated α-synuclein inserts shallowly into only one 80 leaflet of the bilayer (the outer leaflet of the vesicle in the case of our experiments) 4, 36 . The enhanced pressure within the outer leaflet has been speculated to be one of the major driving forces for the formation of external membrane protrusions 32 . If the membrane expansion we observed is a direct result of α-85 synuclein membrane insertion, two consequences should be expected. First, the amount of area expansion by individual molecules would be similar to, or smaller than, the size of α-synuclein membrane binding site. Secondly, in order to expand the two leaflets simultaneously, there would have to be a pathway 90 through which lipids can flip across the bilayer within our time resolution (about 4 seconds) 37 . Contrary to the first expectation, however, the measured area expansion constant is larger than the size of membrane binding site, especially on the plasma membrane mimicking GUVs. This 95 indicates that the observed membrane expansion is not achieved merely by α-synuclein insertion. Through lipid flip-flop, the area asymmetry induced by α-synuclein insertion can be released, resulting in an increase in bilayer membrane area 37 . The trans-membrane flip-flop rate is 100 extremely slow for phospholipid bilayers 38 . Therefore, to test the second expectation, we investigate whether the presence of membrane bound α-synuclein can greatly enhance the transmembrane dynamics of lipids. To achieve this, we used a classical quenching assay based on the 105 dye NBD-PE, which was incorporated homogeneously into 100nm DOPS LUVs. The fluorescence of NBD-PE was irreversibly quenched in the presence of Na2S2O4 (SDT), a chemical which does not permeate the lipid bilayer 38 . Therefore, when SDT is added into NBD-PE containing LUVs, dyes on the 110 outer leaflets of the vesicles will be quenched, leading to a roughly 50% reduction of the total fluorescence signal. Furthermore, a nearly 100% quenching of fluorescence is expected if α-synuclein were to swiftly flip the lipids, thereby exposing NBD originally on the inner leaflets to the fluorescence quencher. However, much weaker effects were observed in the presence of α-synuclein, similar to that of casein, a cytosolic protein which is inert to lipid membranes (Fig. 6) . Therefore, membrane binding of α-synuclein does not promote lipid flip-flop 5 across the bilayer under our experimental conditions, and the insertion of α-synuclein is unlikely to play an important role in the membrane expansion observed here. 
The membrane expansion effect is most likely a result of α-synuclein induced membrane thinning
Having eliminated the possibility that our observed area 25 expansion is a result of α-synuclein interfering with membrane undulations or lipid trans-membrane dynamics, we next discuss the possibility of a role for α-synuclein in directly stretching or thinning the bilayer. The membrane binding free energy ∆G of an α-synuclein molecule on negatively charged membranes can be 30 calculated from a published value of the α-synuclein membrane binding constant KD (in terms of lipid concentration). We estimated the membrane binding energy as ∆G = −k B Tln(K D n ⁄ ) = 16k B T, where KD =2.25μM and n=23 is the number of lipids bound by one α-synuclein molecule 39 . This 35 binding free energy sets an upper limit for the amount of energy α-synuclein molecules can utilize to expand the bilayer. Lipid bilayers are comparatively hard to directly stretch (via increasing the lipid distance via application of a lateral force). Considering the typical membrane stretch elastic modulus (E =0.2 N/m 40 ), it 40 can be seen that an energy of more than 1000 kBT is required for stretching an area of 22nm 2 per molecule (the area expansion constant measured on DOPS GUVs) out of the bilayer. Therefore, the area increase we observed cannot be the result of direct membrane stretching. 45 On the other hand, the transverse elastic modulus of membrane bilayers , which describes the change in membrane thickness upon applying a force vertical to the membrane surface, is typically between 0.4~4 MPa 41 . The membrane binding energy of one α-synuclein molecule can lead to a squeezing of a piece of 
Typical bilayers are about 4nm thick and molecular dynamic simulations indicate that individual α-synuclein molecules usually act upon a membrane area of about 50nm 2 11 . Taking a=50nm 2 and d=4nm in equation (2), the binding energy of one 60 α-synuclein monomer can potentially induce an area expansion of 4~240nm 2 . Notably, our experimentally measured area expansion constants do fall into this range. Interestingly, a recent study hypothesized that α-synuclein can expand the membrane through inducing lipid interdigitation 9 . The 65 binding energy of α-synuclein is sufficient to enable squeezing a 50nm 2 bilayer into a compact monolayer, thereby inducing an area expansion of about 50nm 2 42, 43 , which is, again, in agreement with our results. In summarizing these considerations, we conclude that the membrane expansion we observed is most 70 likely a result of α-synuclein induced membrane thinning.
Membrane tubulation or fragmentation follows the area expansion process α-synuclein has been reported to induce dramatic membrane remodelling such as tubulation and total fragmentation of the 75 membrane in vitro [5] [6] [7] [8] . Indeed, in our hands GUVs containing pure DOPS almost always collapse after a certain amount of area expansion (Fig. 7a, 7e ). In our setup, the initiation of high curvature membrane tubes can be revealed by a decrease in apparent GUV area. For BAR domain proteins, this phenomenon 80 has been well described by a linear curvature instability theory 26 . Briefly, GUVs under certain membrane tensions become tubulated when protein densities on the membrane reach a critical level. However, for α-synuclein, membrane area reduction, and thereby tubulation, was only observed on a small fraction of 85 GUVs after the initial area expansion process (Fig. 7b-e) . Therefore, the underlying mechanism of α-synuclein induced membrane tubulation may be more complex than that of BAR domain proteins. One reason for this complication might be related to the initial thinning phase during the α-synuclein 90 membrane interaction. If the membranes are initially thinned by the binding of α-synuclein, the bilayer may become interdigitated and eventually form cylindrical micelles as oppose to membrane tubes 5 . Regardless of the complexity of the mechanism, our results 95 clearly demonstrate that α-synuclein-induced membrane tubulation only occurs after a thinning phase of the bilayer. This in fact has important biological implications since the ability to generate membrane curvature is directly related to the potential roles of α-synuclein in mediating endocytosis. Moreover, 100 membrane thinning can lower the membrane bending modulus 20 . This effect is in turn expected to affect the functions of other membrane curvature generating proteins. The influence of α-synuclein on vesicle trafficking processes will be a topic for future research. In summary, we found substantial membrane thinning induced by α-synuclein binding. We also demonstrated that membrane tubulation can occur after the initial membrane thinning process as an additional α-synuclein membrane interaction mode. 
